Host-guest complexation of omeprazole, pantoprazole and rabeprazole sodium salts with cyclodextrins: An NMR study on solution structures and enantiodiscrimination power

Journal of Inclusion Phenomena and Macrocyclic Chemistry

Volumn 73, Issue 1-4, 2012, Pages 225-236

  Redondo, Jordi ^a   Capdevila, Anna ^a   Latorre, Isabel ^a   Bertrán, Jordi ^a  

^a Department of Research and Development   (Spain)

Author keywords

1H and 19F NMR; Enantiorecognition; Omeprazole; Pantoprazole; Rabeprazole; ROESY

Indexed keywords

EID: 84862604376     PISSN: 09230750     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10847-011-0046-z     Document Type: Article

References (48)

1. 13C NMR study Magn. Reson. Chem. 42 712 714 10.1002/mrc.1409 1:CAS:528: DC%2BD2cXmtlKns7s%3D
2. P Lindberg A Brändström B Wallmark H Mattsson L Rikner KJ Hoffman 1990 Omeprazole: the first proton pump inhibitor Med. Res. Rev. 10 1 54 10.1002/med.2610100102 1:CAS:528:DyaK3cXptFSnsA%3D%3D
3. S Shi U Klotz 2008 Proton pump inhibitors: an update of their clinical use and pharmacokinetics Eur. J. Clin. Pharmacol. 64 935 951 10.1007/s00228-008-0538-y 1:CAS:528:DC%2BD1cXht1Sqs7jN
4. L Olbe E Carlsson P Lindberg 2003 A proton-pump inhibitor expedition: the case histories of omeprazole and esomeprazole Nat. Rev. Drug Discov. 2 132 139 10.1038/nrd1010 1:CAS:528:DC%2BD3sXot12lsA%3D%3D
5. T Andersson L Weidolf 2008 Stereoselective disposition of proton pump inhibitors Clin. Drug Investig. 28 263 279 10.2165/00044011-200828050-00001 1:CAS:528:DC%2BD1cXntVSru7k%3D
6. Anon.: Development of new stereoisomeric drugs. Food and Drug Administration. http://www.fda.gov/Drugs/ GuidanceComplianceRegulatoryInformation/Guidances/ucm122883.htm. Accessed 5 September 2011
7. Branch, S.: International regulation of chiral drugs. In: Subramanian, G. (ed.) Chiral Separation Techniques. A Practical Approach, pp. 319-342. Wiley-VCH, Weinheim (2001)
8. GR Weisman 1983 Nuclear magnetic resonance analysis using chiral solvating agents Asymm. Synth. 1 153 171 1:CAS:528:DyaL2cXktVKiu7o%3D
9. TJ Wenzel 2000 Lanthanide chiral solvating agent couples as chiral NMR shift reagents Trends Org. Chem. 8 51 64 1:CAS:528:DC%2BD3MXovFGjsL0%3D
10. S Yamaguchi 1983 Nuclear magnetic resonance analysis using chiral derivatives Asymm. Synth. 1 125 152 1:CAS:528:DyaL2cXhsFGqs7c%3D
11. TJ Wenzel JD Wilcox 2003 Chiral reagents for the determination of enantiomeric excess and absolute configuration using NMR spectroscopy Chirality 15 256 270 10.1002/chir.10190 1:CAS:528:DC%2BD3sXhvFyqsbw%3D
12. Courtieu, J., Lesot, P., Meddour, A., Merlet, D., Aroulanda, C.: Chiral liquid crystal NMR: a tool for enantiomeric analysis. In: Grant, D.M., Harris, R. (eds.) Encyclopedia of Nuclear Magnetic Resonance, pp. 497-505. Wiley, New York (2002)
13. M Sugiura A Kimura H Fujiwara 2006 Discrimination of enantiomers by means of NMR spectroscopy using chiral liquid crystalline solution: application to triazole fungicides, uniconazole and diniconazole Magn. Reson. Chem. 44 121 126 10.1002/mrc.1731 1:CAS:528:DC%2BD28Xht12rtr4%3D
14. D Greatbanks R Pickford 1987 Cyclodextrins as chiral complexing agents in water, and their application to optical purity measurements Magn. Reson. Chem. 25 208 215 10.1002/mrc.1260250306 1:CAS:528:DyaL1cXlsFelsA%3D%3D
15. 1H NMR study on the solution structures of their host-guest complexes Chirality 11 694 700 10.1002/(SICI)1520-636X(1999)11:9<694::AID-CHIR5>3.0.CO;2-W 1:CAS:528:DyaK1MXmvFahs7Y%3D
16. J Szejtli 1998 Introduction and general overview of cyclodextrin chemistry Chem. Rev. 98 1743 1753 10.1021/cr970022c 1:CAS:528:DyaK1cXksV2itrw%3D
17. Cserhati, T.: Cyclodextrins in HPLC. Encyclopedia of Chromatography, vol. 1, 3rd edn., pp. 546-556 (2010)
18. Cserhati, T.: Cyclodextrins in GC. Encyclopedia of Chromatography, vol. 1, 3rd edn., pp. 536-545 (2010)
19. Chankvetadze, B.: Chiral compounds: separation by CE and MEKC with cyclodextrins. Encyclopedia of Chromatography, vol. 1, 3rd edn, pp. 419-424 (2010)
20. M Thunhorst U Holzgrabe 1998 Utilizing NMR spectroscopy for assessing drug enantiomeric composition Magn. Reson. Chem. 36 211 216 10.1002/(SICI)1097- 458X(199803)36:3<211::AID-OMR246>3.0.CO;2-Y 1:CAS:528:DyaK1cXhslChtb8%3D
21. R Cirilli R Ferretti B Gallinella E De Santis L Zanitti F La Torre 2008 High-performance liquid chromatography enantioseparation of proton pump inhibitors using the immobilized amylose-based Chiralpak IA chiral stationary phase in normal-phase, polar organic and reversed-phase conditions J. Chromatogr. A 1177 105 113 10.1016/j.chroma.2007.11.027 1:CAS:528: DC%2BD2sXhsVOls7jK
22. JJ Berzas-Nevado G Castaneda-Penalvo RM Rodríguez-Dorado 2005 Method development and validation for the separation and determination of omeprazole enantiomers in pharmaceutical preparations by capillary electrophoresis Anal. Chim. Acta 533 127 133 10.1016/j.aca.2004.11.018
23. L Toribio C Alonso MJ del Nozal JL Bernal JJ Jiménez 2006 Enantiomeric separation of chiral sulfoxides by supercritical fluid chromatography J. Sep. Sci. 29 1363 1372 10.1002/jssc.200600009 1:CAS:528:DC%2BD28XptFKis7k%3D
24. A Figueiras JMG Sarraguça RA Carvalho AACC Pais FJB Veiga 2007 Interaction of omeprazole with a methylated derivative of β-cyclodextrin: phase solubility, NMR spectroscopy and molecular simulation Pharm. Res. 24 377 389 10.1007/s11095-006-9161-8 1:CAS:528:DC%2BD2sXjtFGjsQ%3D%3D
25. J Redondo A Capdevila I Latorre 2010 Use of (S)-BINOL as NMR chiral solvating agent for the enantiodiscrimination of omeprazole and its analogs Chirality 22 472 1:CAS:528:DC%2BC3cXks1GnsL8%3D
26. Coppi, L., Berenguer, R.: Method for obtaining derivatives of [[substituted-pyridyl)methyl]thio]benzimidazole, useful as intermediates for omeprazole and related antiulcer agents. PCT Int. Appl. WO 2001079194 A1
27. Berenguer, R., Campón, J., Coppi, L.: Method for oxidizing a thioether group into a sulfoxide group in benzimidazole derivatives. PCT Int. Appl. WO 2001068594 A1
28. Coppi, L., Berenguer, R., Gasanz, Y., Medrano, J.: Process for the preparation of optically active derivatives of 2-(2-pyridylmethylsulfinyl)- benzimidazole via inclusion complex with 1,1́-binaphthalene-2,2́- diol. PCT Int. Appl. WO 2006094904 A1
29. Anon.: Esomeprazole magnesium trihydrate monograph. European Pharmacopoeia 6th edition 2009 ( http://online.pheur.org/entry.htm )
30. 1H NMR study on the solution structures of their host-guest complexes Chirality 11 694 700 10.1002/(SICI)1520-636X(1999)11:9<694::AID-CHIR5>3. 0.CO;2-W 1:CAS:528:DyaK1MXmvFahs7Y%3D
31. J Szejtli 1998 Introduction and general overview of cyclodextrin chemistry Chem. Rev. 98 1743 1753 10.1021/cr970022c 1:CAS:528:DyaK1cXksV2itrw%3D
32. Cserhati, T.: Cyclodextrins in HPLC. Encyclopedia of Chromatography, vol. 1, 3rd edn., pp. 546-556 (2010)
33. Cserhati, T.: Cyclodextrins in GC. Encyclopedia of Chromatography, vol. 1, 3rd edn., pp. 536-545 (2010)
34. Chankvetadze, B.: Chiral compounds: separation by CE and MEKC with cyclodextrins. Encyclopedia of Chromatography, vol. 1, 3rd edn, pp. 419-424 (2010)
35. M Thunhorst U Holzgrabe 1998 Utilizing NMR spectroscopy for assessing drug enantiomeric composition Magn. Reson. Chem. 36 211 216 10.1002/(SICI)1097- 458X(199803)36:3<211::AID-OMR246>3.0.CO;2-Y 1:CAS:528:DyaK1cXhslChtb8%3D
36. R Cirilli R Ferretti B Gallinella E De Santis L Zanitti F La Torre 2008 High-performance liquid chromatography enantioseparation of proton pump inhibitors using the immobilized amylose-based Chiralpak IA chiral stationary phase in normal-phase, polar organic and reversed-phase conditions J. Chromatogr. A 1177 105 113 10.1016/j.chroma.2007.11.027 1:CAS:528: DC%2BD2sXhsVOls7jK
37. JJ Berzas-Nevado G Castaneda-Penalvo RM Rodríguez-Dorado 2005 Method development and validation for the separation and determination of omeprazole enantiomers in pharmaceutical preparations by capillary electrophoresis Anal. Chim. Acta 533 127 133 10.1016/j.aca.2004.11.018
38. L Toribio C Alonso MJ del Nozal JL Bernal JJ Jiménez 2006 Enantiomeric separation of chiral sulfoxides by supercritical fluid chromatography J. Sep. Sci. 29 1363 1372 10.1002/jssc.200600009 1:CAS:528:DC%2BD28XptFKis7k%3D
39. A Figueiras JMG Sarraguça RA Carvalho AACC Pais FJB Veiga 2007 Interaction of omeprazole with a methylated derivative of β-cyclodextrin: phase solubility, NMR spectroscopy and molecular simulation Pharm. Res. 24 377 389 10.1007/s11095-006-9161-8 1:CAS:528:DC%2BD2sXjtFGjsQ%3D%3D
40. J Redondo A Capdevila I Latorre 2010 Use of (S)-BINOL as NMR chiral solvating agent for the enantiodiscrimination of omeprazole and its analogs Chirality 22 472 1:CAS:528:DC%2BC3cXks1GnsL8%3D
41. Coppi, L., Berenguer, R.: Method for obtaining derivatives of [[substituted-pyridyl)methyl]thio]benzimidazole, useful as intermediates for omeprazole and related antiulcer agents. PCT Int. Appl. WO 2001079194 A1
42. Berenguer, R., Campón, J., Coppi, L.: Method for oxidizing a thioether group into a sulfoxide group in benzimidazole derivatives. PCT Int. Appl. WO 2001068594 A1
43. Coppi, L., Berenguer, R., Gasanz, Y., Medrano, J.: Process for the preparation of optically active derivatives of 2-(2-pyridylmethylsulfinyl)- benzimidazole via inclusion complex with 1,1́-binaphthalene-2,2́- diol. PCT Int. Appl. WO 2006094904 A1
44. Anon.: Esomeprazole magnesium trihydrate monograph. European Pharmacopoeia 6th edition 2009 ( http://online.pheur.org/entry.htm )
45. 1H NMR spectra of organic compounds J. Org. Chem. 71 4103 4110 10.1021/jo060229i 1:CAS:528:DC%2BD28XjslKltrY%3D
46. A Figueiras JMG Sarraguça AACC Pais FJB Veiga RA Carvalho 2008 New insight into the discrimination between omeprazole enantiomers by cyclodextrins in aqueous solution J. Incl. Phenom. Macrocycl. Chem. 62 345 351 10.1007/s10847-008-9477-6 1:CAS:528:DC%2BD1cXhtlGrtb3O
47. SS Braga P Ribeiro-Claro M Pillinger IS Gonçalves AC Fernandes F Pereira CC Romao PB Correa JJC Teixeira-Dias 2003 Interactions of omeprazole and precursors with β-cyclodextrin host molecules J. Incl. Phenom. Macrocycl. Chem. 47 47 52 10.1023/B:JIPH.0000003924.14479.9c 1:CAS:528:DC%2BD3sXptVSmuro%3D
48. Scott, R.L.: Some comments on the Benesi Hildebrand equation. Rec. Trav. Chim. 75, 787 (1956)